	Effects of laparoscopic splenectomy and azygoportal disconnection on immune remodeling in cirrhosis patients with portal hypertension bleeding: a 1-year prospective study. Surg Endosc Cai J, Wan B, Chen C, He C, Zhou B, Jin S, Zhang C, Bai D, Jiang G. PMID: 42680927 [PubMed - as supplied by publisher]
	Spleen stiffness measurement rules out high-risk varices in patients with chronic portal vein thrombosis without cirrhosis. J Hepatol Moga L, Payancé A, Téllez L, Saltini D, Giuli L, Ojeda A, Dajti E, Liusina E, Capinha F, Bettinger D, Monllor-Nunell T, Venu A, Nair G, Elkrief L, Silva J, Meszaros M, Peck-Radosavljevic M, Groba SR, Stern C, Castéra L, Praktiknjo M, Guiu B, Valsan A, Ferrusquía-Acosta J, Ferreira CN, Nadinskaya M, Ravaioli F, Turon F, Santopaolo F, Schepis F, Albillos A, Rautou PE, Plessier A, ERN RARE-LIVER; a study of VALDIG, an EASL consortium. PMID: 42679862 [PubMed - as supplied by publisher]
	Measuring quality of life in advanced chronic liver disease with FACT-Hep: Findings from the PAL LIVER trial. Hepatol Commun Verma M, John BV, Rockey D, Barritt S, Navarro V, Shaw LK, Kosinski A, Tapper EB, Desai A. PMID: 42678241 [PubMed - indexed for MEDLINE]
	Diagnostic Accuracy of Leucocyte Esterase Reagent Strips for Spontaneous Bacterial Peritonitis in Cirrhosis With Ascites. Health Sci Rep Mwinyi SA, Sindato EM, Muhimbura E, Kawishe GJ, Yahaya JJ. PMID: 42676743 [PubMed]
	Impact of Cirrhosis Outcome Risk Estimator (CORE) Risk Score on Prognosis Following Hepatectomy for Hepatocellular Carcinoma. Anticancer Res Takagi K, Nishiyama T, Kimura J, Fuji T, Yasui K, Fujiwara T. PMID: 42674693 [PubMed - indexed for MEDLINE]
	MRI in MASLD: technical foundations and guideline-based applications. BMJ Open Gastroenterol Pu J, Zhu L, Wu Y, Ping F, Xu J, Zhou K, Wang X, Pan J. PMID: 42665335 [PubMed - indexed for MEDLINE]
	Sodium-glucose cotransporter-2 inhibitor use and clinical outcomes in patients with cirrhosis: a propensity-matched real-world cohort study. Eur J Gastroenterol Hepatol Helal E, Shehi E, Al Homaid A, Dervishi M, Tripathi DK. PMID: 42664456 [PubMed - indexed for MEDLINE]
	Assessing clinical outcomes in cirrhotic patients with thromboembolic complications. Eur J Gastroenterol Hepatol Banks MC, Ahanotu A, Lee KJ, Abougergi M. PMID: 42664454 [PubMed - indexed for MEDLINE]
	Prognostic value of different sarcopenia assessment methods for mortality in patients with liver cirrhosis: a systematic review and meta-analysis. Front Nutr Xie W, Shi W, Xu R, Shang Z, Huo G, Zhang Z, Yang Z. PMID: 42661677 [PubMed]
	E3 Ubiquitin Ligases in MASH-Associated Liver Fibrosis: Mechanisms and Therapeutic Opportunities. Liver Int Oh AR, Jeong Y, Jung YH, Kim YU, Gi H, Kim DW, Choi YD, Lee SB, Kim K. PMID: 42661460 [PubMed - indexed for MEDLINE]
	A Computerized Clinical Decision Support Tool Increases Rates of Confirmatory Testing in MASLD Patients at Risk for Advanced Fibrosis. J Am Board Fam Med Xiao T, Miller J, Rowland B, Bundy R, Moses A, Witek L, Obermiller C, Dharod A, Rudnick S. PMID: 42660653 [PubMed - indexed for MEDLINE]
	Noninvasive Detection of Clinically Significant Fibrosis in Biopsy-Proven MASLD: A Retrospective Cross-Sectional Diagnostic Accuracy Study. Medicina (Kaunas) Eksi O, Atay K, Eskazan T, Abishov E, Canbakan M, Canbakan B. PMID: 42654424 [PubMed - indexed for MEDLINE]
	Point-of-Care Ultrasound Assessment of Pulmonary and Venous Congestion in Patients with Liver Cirrhosis and Acute Kidney Injury Receiving Albumin: An Exploratory Prospective Study from a Resource-Limited Tertiary Care Center in Western Mexico. Medicina (Kaunas) Rubio-Mora BR, Ochoa-Rodríguez MA, Ambriz-Alarcón MA, Lozano-Sabido EA, Meugniot-García H, Jiménez-Pérez DM, Calleros-Camarena ÁI, Ramírez-Ochoa S, Vicente-Hernández B, Cervantes-Guevara G, Rabago-Solorio E, Cervantes-Perez E. PMID: 42654357 [PubMed - indexed for MEDLINE]
	Therapeutic Targets for Hepatic Fibrosis Driven by Hypoxia-Mediated Hepatic Stellate Cell Activation. Biomolecules Li W, Li T, Mao J. PMID: 42650757 [PubMed - indexed for MEDLINE]
	ALG-055009 in non-cirrhotic adults with metabolic dysfunction-associated steatohepatitis (HERALD): a randomised, double-blind, placebo-controlled, phase 2a trial. Lancet Gastroenterol Hepatol Loomba R, Wang S, Desai D, Santillano D, Lucas KJ, Neff G, Bianco AC, Bruinstroop E, Su Y, Achneck HE, Le K, Fitzgerald M, Wu M, Lin TI, Chanda SM, Blatt LM, Mantzoros CS. PMID: 42648297 [PubMed - as supplied by publisher]
	Targeting PPAR-Regulated Pathways to Treat Cholestatic Liver Diseases: Novel Applications of Liquid Biopsies. Cells Hayes CM, Cross DR, Achour B, Ghonem NS. PMID: 42645170 [PubMed - indexed for MEDLINE]
	Clinical Trial: Intensive Supervised Nutritional Therapy Versus Guideline-Based Nutritional Advice for Sarcopenia in Decompensated Cirrhosis-A Randomised Controlled Trial. Aliment Pharmacol Ther Dhaked GK, Sharma PN, Sharma KK, Maharshi S, Agrawal S, Pokharna R, Nijhawan S, Sharma SS. PMID: 42643064 [PubMed - as supplied by publisher]
	Portal Vein Thrombosis Risk in Cirrhotic Patients With Portal Hypertension on Beta-Blockers: A Multi-Institutional Cohort Study. Liver Int Abosheaishaa H, Elfert K, Abusuliman M, Ismail A, Olimy A, Alzamzamy AE, Omran A, Rizzo V, Nassar M, El-Kassas M. PMID: 42642993 [PubMed - indexed for MEDLINE]
	Risk stratification of non-acute decompensation in alcohol-related cirrhosis using the red cell distribution width-to-platelet ratio. Dig Liver Dis Romeo M, Domislovi, Di Nardo F, Napolitano C, Vaia P, Basile C, Mrzljak A, Federico A, Dallio M. PMID: 42642231 [PubMed - as supplied by publisher]
	Association between thyroid feedback quartile index and FIB-4-defined fibrosis risk in patients with metabolic dysfunction-associated steatotic liver disease, type 2 diabetes mellitus, and treated primary hypothyroidism: an exploratory cross-sectional study. Front Endocrinol (Lausanne) Wang Y, Xie J, Wang Y, Liu X, Zhou X. PMID: 42638674 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 39204

Page 1 of 1961



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy